Skip to main content
. 2021 Jun 17;13(6):900. doi: 10.3390/pharmaceutics13060900

Figure 3.

Figure 3

TEM micrograph of (A) AuNPs, (B) Au:G5D, (C) Au:G5D-mRNA nanocomplex, (D) Au:G5D:FA, and (E) Au:G5D:FA-mRNA nanocomplex. Nanocomplexes were prepared at optimum binding ratios of 3:1 (w/w) for Au:G5D-mRNA and 4:1 (w/w) for Au:G5D:FA-mRNA, respectively.